Endra signs binding merger agreement with ASP Isotopes and partners
Endra Life Sciences signed a merger agreement with ASP Isotopes, Renergen, and Noble Africa to combine their businesses into a single entity. This strategic combination aims to leverage the mutual strengths of the two companies in the medical and isotope markets.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day